Stock Analysis of ABVC Biopharma Inc (ABVC) - Birds Eye View

1W   2W   1M   3M   1Y   2Y   5Y   
Overview
Code ABVC
Close 1.45
Change 0.110 / 8.21 %
Volume 384121
Vol Change -125245.00 / 24.59 %
IndustryBiotechnology
SectorHealthcare
AIO Strength Index
Technical StrengthBullish
Growth Index Very Low Growth Stock
Value Index Poor Value Stock
Profitability Index Poor Profitability Stock
Stability Index Poor Stability Stock


Fundamental View of ABVC Biopharma Inc


Highs/Lows of ABVC Biopharma Inc
PeriodOld priceStock ReturnS&P 500 ReturnsHighLowHigh DateLow Date
One Week1.68 13.69 % 0.425 % 1.70991.220128-Nov-2301-Dec-23
Two Week1.69 14.20 % 0.493 % 2.221.220121-Nov-2301-Dec-23
One Month1.17 23.93 % 4.85 % 2.221.0221-Nov-2313-Nov-23
Three Month1.24 16.94 % 1.20 % 3.350.69726-Oct-2306-Oct-23
Six Months0.6661 117.69 % 6.71 % 6.870.33326-Jul-2324-Jul-23
One year0.765 89.54 % 12.23 % 6.870.33326-Jul-2324-Jul-23
Two year2.93 50.51 % 0.691 % 6.870.33326-Jul-2324-Jul-23
Five year1.6 9.38 % 69.25 % 6.870.33326-Jul-2324-Jul-23
Ten year0.00413881 34934.22 % 154.89 % 29.953.1837E-410-May-2122-Jan-15


Technical View of ABVC Biopharma Inc






Charts of ABVC Biopharma Inc


Returns of ABVC Biopharma Inc with Peers
Period / StockABVCONVOKZIAEDSA
1 Week-13.69%1.69%-25.13%7.64%
1 Mth23.93%-29.41%-4.54%-4.52%
3 Mth16.94%7.14%-53.85%303.82%
6mth117.69%-30.23%-63.00%277.86%
1 Year89.54%-21.05%-30.05%244.90%
2 Year-50.51%-72.73%-95.11%-36.82%
5 Years-9.38%-94.06%-83.66%-50.58%


Compare Fundamentals of ABVC Biopharma Inc with Peers
Ratio / StockABVCONVOKZIAEDSA
PE-2.60-0.474-6.43-5.77
P/B6.850.5959.315.65
ROA-89.56-103.62-61.14-77.75
ROE-262.96-125.64-144.62-97.91
Debt To Equity0.7300.03210.1490.0020
Revenue969783
172.57 %
370000
75.33 %
0
100.00 %
0
%
Net Income-16312.37 K
27.06 %
-17259.00 K
50.76 %
-20465.18 K
16.97 %
-17548.92 K
31.52 %


Technicals of ABVC Biopharma Inc with Peers
Technical / StockABVCONVOKZIAEDSA
ADX44.9529.3818.0844.57
CMF-0.127-0.166-0.238-0.288
MFI90.1180.4669.2967.28
RSI52.4245.1733.1458.68
MACD Abv SignalFalseFalseFalseTrue
Price Above 50 MATrueFalseFalseTrue
Price Above 200 MATrueFalseFalseTrue


About : ABVC Biopharma Inc


Address : 44370 Old Warm Springs Boulevard, Fremont, CA, United States, 94538
Tel : 510 668 0881
URL : https://www.abvcpharma.com
Code : ABVC, ISIN : US00091F1066, Exchange : NASDAQ, Country : USA
Fiscal Year End : December
IPO date : 11_Oct_2017
Employee Count : 19

ABVC BioPharma, Inc., a clinical stage biopharmaceutical company, develops drugs and medical devices to fulfill unmet medical needs in the United States. The company is developing ABV-1501, which is in Phase II clinical trials a combination therapy for triple negative breast cancer; ABV-1504 has completed Phase II clinical trials for major depressive disorders; ABV-1505, which is in Phase II clinical trials for adult attention deficit hyperactivity disorder; ABV-1703, which is in Phase II clinical trials for the treatment of metastatic pancreatic cancer; ABV-1702, which is in Phase II clinical trials to treat myelodysplastic syndromes; ABV-1601 that is in Phase I/II clinical trials for treating depression in cancer patients; ABV-1701 Vitargus that is in Phase II clinical trials for the treatment of retinal detachment or vitreous hemorrhage; and ABV-1519, which is in Phase I/II clinical trials for the treatment of non-small cell lung cancer. ABVC BioPharma, Inc. has a co-development agreement with Rgene Corporation; and collaboration agreements with BioHopeKing Corporation and BioFirst Corporation. The company is based in Fremont, California. ABVC BioPharma, Inc. is a subsidiary of YuanGene Corporation.


Note : All Data Generated at the End of Trading Hours (EOD Data)